戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 209作成日:2026年10月23日

1-(Benzyloxy)-4-bromo-2-methoxybenzene → (3R)-1-(3-methoxy-4-phenylmethoxyphenyl)-3-methylpiperazine

https://huagongshe.com/ja/reaction/209

反応式

関与物質

役割名称HCID仕込み量
反応物1-(Benzyloxy)-4-bromo-2-methoxybenzeneHCID 3613128—
反応物tert-Butyl (2R)-2-methylpiperazine-1-carboxylateHCID 10262201—
試薬Sodium t-butoxideHCID 23676156—
触媒Binap, (A+-)-HCID 634876—
触媒Bis(dibenzylideneacetone)palladiumHCID 9811564—
溶媒TolueneHCID 1140—
生成物(3R)-1-(3-methoxy-4-phenylmethoxyphenyl)-3-methylpiperazineHCID 7027896040.26%

反応条件

温度80 °C

反応手順

To (R)-tert-butyl 2-methylpiperazine-1-carboxylate (0.717 g, 3.58 mmol), TRIS(DIBENZYLIDENEACETONE)DIPALLADIUM(0) (0.094 g, 0.10 mmol) and 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl (0.085 g, 0.14 mmol) and Sodium tert-butoxide (0.459 g, 4.78 mmol) was added a solution of 1-(benzyloxy)-4-bromo-2-methoxybenzene (1 g, 3.41 mmol) in Toluene (25 mL). The reaction was heated to 80 °C for 18 hours. the reaction was allowed to cool to room temperature and diluted with dcm (50 ml). This was washed with water (2 x 50 ml), dried over sodium sulfate, filtered and the solvent removed under reduced pressure. The crude product was dissolved in hydrochloric acid solution in methanol (4N, 20 ml) and stirred at room temprature overnight. The solvent was removed under reduced pressure.The crude product was purified by ion exchange chromatography, using an SCX column. The desired product was eluted from the column using 7M NH3/MeOH and pure fractions were evaporated to dryness to afford (R)-1-(4-(benzyloxy)-3-methoxyphenyl)-3-methylpiperazine (0.429 g, 40.3 %) as a yellow gum.

情報源と証拠

出典データセット750 AstraZeneca ELN dataset
ORD IDord-80551a125bb34e24a0d215f47bcdf5d9
出典メモ750 AstraZeneca ELN dataset